207 related articles for article (PubMed ID: 26488422)
1. Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.
Cohen AS; Patek R; Enkemann SA; Johnson JO; Chen T; Toloza E; Vagner J; Morse DL
Bioconjug Chem; 2016 Feb; 27(2):427-38. PubMed ID: 26488422
[TBL] [Abstract][Full Text] [Related]
2. Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.
Huynh AS; Estrella V; Stark VE; Cohen AS; Chen T; Casagni TJ; Josan JS; Lloyd MC; Johnson J; Kim J; Hruby VJ; Vagner J; Morse DL
Mol Pharm; 2016 Feb; 13(2):534-44. PubMed ID: 26713599
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging.
Josan JS; Morse DL; Xu L; Trissal M; Baggett B; Davis P; Vagner J; Gillies RJ; Hruby VJ
Org Lett; 2009 Jun; 11(12):2479-82. PubMed ID: 19445485
[TBL] [Abstract][Full Text] [Related]
5. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
[TBL] [Abstract][Full Text] [Related]
6. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.
Ryu EK; Wu Z; Chen K; Lazarus LH; Marczak ED; Sasaki Y; Ambo A; Salvadori S; Ren C; Zhao H; Balboni G; Chen X
J Med Chem; 2008 Mar; 51(6):1817-23. PubMed ID: 18311909
[TBL] [Abstract][Full Text] [Related]
8. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
9. Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.
Balboni G; Fiorini S; Baldisserotto A; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
J Med Chem; 2008 Aug; 51(16):5109-17. PubMed ID: 18680274
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.
Kim EM; Park EH; Cheong SJ; Lee CM; Jeong HJ; Kim DW; Lim ST; Sohn MH
Bioconjug Chem; 2009 Jul; 20(7):1299-306. PubMed ID: 19534520
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a Novel IR-822-Met near-infrared probe for in vivo tumor diagnosis.
Sun C; Zhang H; Du W; Wang B; Ji M
Biotechnol Lett; 2017 Apr; 39(4):491-499. PubMed ID: 28050673
[TBL] [Abstract][Full Text] [Related]
13. Novel C-terminus modifications of the Dmt-Tic motif: a new class of dipeptide analogues showing altered pharmacological profiles toward the opioid receptors.
Pagé D; Naismith A; Schmidt R; Coupal M; Labarre M; Gosselin M; Bellemare D; Payza K; Brown W
J Med Chem; 2001 Jul; 44(15):2387-90. PubMed ID: 11448220
[TBL] [Abstract][Full Text] [Related]
14. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
Chen H; Chung NN; Lemieux C; Zelent B; Vanderkooi JM; Gryczynski I; Wilkes BC; Schiller PW
Biopolymers; 2005; 80(2-3):325-31. PubMed ID: 15614807
[TBL] [Abstract][Full Text] [Related]
15. Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
Pagé D; McClory A; Mischki T; Schmidt R; Butterworth J; St-Onge S; Labarre M; Payza K; Brown W
Bioorg Med Chem Lett; 2000 Jan; 10(2):167-70. PubMed ID: 10673103
[TBL] [Abstract][Full Text] [Related]
16. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.
Zhao N; Zhang C; Zhao Y; Bai B; An J; Zhang H; Wu JB; Shi C
Oncotarget; 2016 Aug; 7(35):57277-57289. PubMed ID: 27329598
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore.
Sarkar A; Adamska-Bartlomiejczyk A; Piekielna-Ciesielska J; Wtorek K; Kluczyk A; Borics A; Janecka A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32957550
[TBL] [Abstract][Full Text] [Related]
19. Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging.
Shaw SK; Liu W; Gómez Durán CFA; Schreiber CL; Betancourt Mendiola ML; Zhai C; Roland FM; Padanilam SJ; Smith BD
Chemistry; 2018 Sep; 24(52):13821-13829. PubMed ID: 30022552
[TBL] [Abstract][Full Text] [Related]
20. A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.
Santagata S; Portella L; Napolitano M; Greco A; D'Alterio C; Barone MV; Luciano A; Gramanzini M; Auletta L; Arra C; Zannetti A; Scala S
Sci Rep; 2017 May; 7(1):2554. PubMed ID: 28566721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
